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ABSTRACT 
BACKGROUND:  
Evidence suggests a role for elevated serum calcium in dysregulated glucose metabolism, linked 
through low-level chronic inflammation. 
OBJECTIVE: 
We investigated the association of elevated serum calcium levels (corrected-for-albumin) with 
markers of dysregulated glucose metabolism and type-II diabetes and tested if these associations 
were accounted for by chronic inflammation in a rural Indian population. 
DESIGN:  
A cross-sectional analysis of participants aged 40-84 years was conducted from the ‘Andhra 
Pradesh Children and Parents Study [N=2699; 52.2% women]. Comprehensive information on 
household, sociodemographics and lifestyle factors; medical and family history; physical 
measurements; blood measurements including fasting plasma glucose (FPG), fasting insulin (FI), 
serum calcium, albumin, phosphorous, vitamin-D (in a sub-set) and creatinine were analysed. 
Additionally, on a random sample of healthy participants (N=1000), inflammatory bio-markers 
(IL-6, IL-18, sICAM-1, adiponectin, hsCRP) were measured and an inflammatory score (IScore) 
calculated.  
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 RESULTS:   
After adjustments for sociodemographics, lifestyle factors and anthropometry the highest 
calcium quartile (Q4 vs.Q1) was associated with FI [β=1.4 µU/ml; 95%CI:1.2,1.5µU/ml; p-
trend:<0.001], ‘homeostasis model assessment’ for insulin resistance (HOMA-IR) [β=1.4; 
95%CI:1.2,1.5; p-trend:<0.001] and modestly associated with FPG [β=2.1 mg/dL; 95%CI:-0.9, 
5.2mg/dL; p-trend:0.058] and prevalent type-II diabetes  [OR=1.6; 95%CI:1.0, 2.6; p-
trend:0.020]. In the healthy sub-group, the association of the highest calcium quartile was similar 
for FI and HOMA-IR. Additional adjustment with IScore did not alter the associations.  Further, 
in a subset, all these associations were independent of endogenous regulators of calcium 
metabolism (serum vitamin-D, phosphorus and creatinine). Independently, after accounting for 
potential confounders, the highest Iscore quartile (Q4 vs.Q1) was positively associated with 
FPG, FI, HOMA-IR and prevalent prediabetes and also with serum calcium levels in men.  
CONCLUSIONS:  
Elevated serum calcium was positively associated with markers of dysregulated glucose 
metabolism and prevalent type-II diabetes in a rural Indian population. Chronic inflammation did 
not mediate this association but was independently associated with markers of dysregulated 
glucose metabolism. Inflammation might be responsible for elevated serum calcium levels in 
men.  
KEY WORDS 
Calcium, glucose metabolism, insulin resistance, type-II diabetes, prediabetes, chronic 
inflammation, India, APCaPS. 
Word Count: 313 
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 INTRODUCTION  
Type-II diabetes is one of the leading causes of morbidity and mortality due to 
noncommunicable diseases (NCDs) globally (1-3). Over the past decade, while major NCDs 
including cardiovascular disease (CVD) and chronic obstructive respiratory disease either 
increased modestly or notably declined in some geographical regions, diabetes has increased 
globally [relative increase from 2006 to 2016: 24·4% (95% CI: 22·7–26·2)  in disability-adjusted 
life-years (DALYs) and 31.1% (95% CI: 28·9–33·4) in absolute deaths] (1-3). The estimated 1.4 
million deaths and over 570 million DALYs due to diabetes in 2016 are also likely 
underestimates (1-2). Asia, with the most populous countries of the world (i.e., China and India), 
is at the epicentre of this burden with a different pattern of disease compared to their Western 
counterparts (3).  Although  demographic and epidemiological transitions may partly explain this 
burden, novel aetiopathological explorations are imperative for planning effective preventive and 
therapeutic strategies (3-4).  
Calcium modulates enzymatic functions in the liver for the production of glucose and break-
down of glycogen. Calcium levels in blood and tissues are vital for secretion of insulin by the 
beta-cells of the pancreas (4). Thus, glucose production and beta-cell function are calcium 
dependent and calcium homeostasis in blood and tissues is important for controlled glucose 
metabolism (4). Elevated serum calcium levels have been associated with an increased risk of 
type-II diabetes in longitudinal studies (5-8) independent of potential confounders including 
adiposity and endogenous regulators of calcium metabolism such as vitamin-D, phosphorus, 
parathyroid hormone (PTH) or renal function (9). Further, cross-sectional studies (10-13) have 
shown positive associations for elevated serum calcium levels with markers of dysregulated 
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 glucose metabolism such as increased levels of fasting glucose, glucose intolerance, insulin 
resistance and defective β-cell function as well as  type-II diabetes.  
Chronic low-levels of inflammation triggered by energy excess is an important biological 
mechanism which may cause elevated serum calcium levels (4) and mediate its association with 
dysregulated glucose metabolism (4, 14). However, given the complexity of endogenous 
(vitamin-D, renal function, hormones) and exogenous regulators (dietary intake, supplements, 
medications such as diuretics) of calcium metabolism (15), testing these associations in different 
settings and populations (9) and understanding the potential biological mechanism underlying 
the associations are vital (15). Data from rural Indian adults, with a different pattern of type-II 
diabetes (3, 16) and distinctive risk exposures such as tobacco chewing, regional dietary patterns, 
possible infectious history and genetics, provide the opportunity to assess the relationship 
between calcium, inflammation and glucose metabolism within a different structure of 
confounders compared to populations more often studied. Andhra Pradesh Children and Parents’ 
Study (APCaPS) is a prospective birth cohort study with data collected from rural Indian 
adolescents and adults at three time points (2003-05; 2009-10; 2011-12) (17).  We evaluated the 
association of serum calcium levels and levels of fasting plasma glucose (FPG), fasting insulin 
(FI), ‘homeostasis model assessment’ for insulin resistance (HOMA-IR) and prevalence of 
prediabetes (FPG 100-125 mg/dL) and type-II diabetes (doctor-diagnosed plus FPG ≥ 126 
mg/dL) in rural Indian adults aged 40+ years using data from the 2011-12 collection round. We 
included additional inflammatory data in a sub-set of healthy participants to test if these 
associations were partly or fully accounted for by chronic inflammation after excluding 
participants with self-reported history of any chronic disease including hypertension, diabetes, 
CVD, chronic obstructive respiratory disease and cancer. 
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  METHODS 
 The analyses in this study used data from the third follow-up of APCaPS (2010-12), a 
prospective cohort study established through long-term follow-up of the Hyderabad Nutrition 
Trial (1987-1990). Brief details of the study design are included as supplemental material along 
with a participant flow chart. A total of 6,944 out of a potential of 10,213 individuals  
participated during this phase. This included adults born between 1987 and 1990, their parents 
and household members. Our analysis included men and women aged 40+ years (N=2699) from 
the third follow-up phase. Comprehensive information on household, socio-demographic, socio-
economic, life-style factors, medical and family history as well as physical measurements 
(anthropometrics and blood pressure) were collected. Fasting blood samples (8-hr) were 
collected and bio-chemical levels of FPG, FI, and serum levels of nutrients including calcium, 
phosphorus as well as vitamin-D in a sub-set (N=1,713) along with full blood count, and kidney 
function tests (e.g., serum creatinine, albumin) were measured. Vitamin-D data was available for 
adults born between 1987 and 1990 and their parents (N=1713/2699) and was not available for 
other members of the household or community. Inflammatory bio-markers IL-6, IL-18, sICAM-
1, adiponectin and hsCRP were measured in a sub-set of randomly selected healthy participants 
aged 40+ years (N=1000) excluding participants with self-reported history of any chronic disease 
including hypertension, diabetes, CVD, chronic obstructive respiratory disease and cancer.  
Data collection (between January 2010 and December 2012) 
Questionnaire data: Structured interviewer-administered questionnaires were used to collect 
data from all participants. Comprehensive data on socio-demographics, socio-economics and 
life-style factors were collected. The study participants lived in rural locations with gradual 
improvements in existing facilities and infrastructure during the entire study period (2003-2012). 
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 This degree of urbanization was calculated using a composite urbanisation score and the 
participants were classified into tertiles. A subset of questions (14/29) from the National Health 
Family Survey-2, (18) was used to estimate socioeconomic position based on information on the 
quality of house, toilet facilities, source of lighting, drinking water, household articles and 
agricultural land. A standard of Living Index (SLI) was derived based on these estimates. 
Clinical assessments: Weight was measured to the nearest 0.1kg with a digital balance (SECA 
899) and standing height measured to the nearest 1 mm with a plastic stadiometer (Leicester 
height measure; supplied by Chasmors, London). Measurements were taken twice and the 
average of two values was used in the analysis. Body mass index (BMI) was calculated as weight 
(kg) / height (m
2
). Systolic and diastolic blood pressure was measured with a validated 
oscillometric device (Omron M5-I, Matsusaka Co., Japan) in the supine position, with 
appropriate cuff sizes. Each measure was taken three times and the average used.  Physical 
Activity Level (PAL) was assessed based on Metabolic Equivalent Tasks (METs) (19) (for 
details please see supplementary material). Hypertension included doctor-diagnosed disease 
and/or a systolic BP ≥140 mm Hg or a diastolic BP ≥90 mm Hg at the time of the interview. 
Diabetes included doctor-diagnosed disease and/or a FPG criterion of > 126 mg/dL at the time of 
the interview. Prediabetes included a FPG criterion of 100-125 mg/dL at the time of the 
interview. 
Bio-chemical measurements: Participants attended morning clinics and were asked to fast 
overnight. Venous blood samples (20mL) were drawn in plain and fluoride vacutainers (Becton 
& Dickinson, USA) by a trained phlebotomist, centrifuged and transferred to the laboratory on 
ice.  All assays, except for FPG and vitamin-D (measured at National Institute of Nutrition, 
Hyderabad, India), were performed in the Genetics and Biochemistry Laboratory of the South 
D
ow
nloaded from
 https://academ
ic.oup.com
/cdn/advance-article-abstract/doi/10.1093/cdn/nzy085/5144764 by London School of H
ygiene & Tropical M
edicine user on 15 January 2019
 Asia Network for Chronic Disease, Public Health Foundation of India, New Delhi. FPG was 
analysed by enzymatic method using glucose oxidase/peroxidase-4- aminophenazone-phenol 
(GOD-PAP) method on the same day and the remaining serum samples were stored at -80
0
C for 
further analysis; FI was analysed on 411 auto-analyser using reagents from Roche Diagnostics 
GmbH, Sandhofer Strasse, Mannheim, which is electro chemiluminescence immune assay based 
on sandwich principle (ECLIA); Albumin by Bromocresol green method and creatinine by 
Jaffe’s method, rate blanked and compensated.. Serum calcium was estimated with 0-
cresolphthalein complex-one under alkaline conditions. Total serum calcium was corrected for 
albumin using the formula: (serum calcium mg/dL) + (0.8 * (4 – serum albumin g/dL)).  
Inorganic phosphate was measured by forming ammonium phosphomolybdenum complex; 
vitamin-D using quantitative high-pressure liquid chromatography and detected at 265 nm by 
using an ultraviolet detector (coefficient of variation (CV) 7%).  Hs-CRP by particle enhanced 
immunoturbidimetry method, IL-6, IL-18, sICAM-1 were assayed using enzyme-linked 
immunoassay (ELISA; Krishgen BioSystems) and adiponectin was assayed by sandwich-assay 
using kits from Mediagnost, Diagnostika GmbH, Germany . The intra-assay and inter-assay CV 
were at <3% and <5 % respectively. 
Homoeostasis Model Assessment for insulin resistance (HOMA-IR) was calculated using the 
formula [(fasting glucose mg/dL* fasting insulin µU/ml)/405] if fasting insulin was not equal to -
1 µU/ml (20). Chronic inflammation was assessed through calculation of a standardised 
composite inflammatory score (Iscore) by summing the z-scores of markers as follows: [(z-score 
IL-6) + (z-score hsCRP) + (z-score IL-18) + (z-score sICAM-1)] – [z-score adiponectin] as 
previously described in Tabung et al in 2016 (21) with the exception of TNF-α (a pro-
inflammatory marker) which was not available. Participants were categorized as anti- or pro-
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 inflammatory based on negative and positive Iscores respectively as described in Tabung et al in 
2016 (21).  
Ethical approval: 
The study received approvals from the ethics committees of the National Institute of Nutrition 
(NIN), the Indian Council of Medical Research (ICMR), Hyderabad, India (latest approval 
03/CR/2011/IV dated:23
rd
 Dec 2011) and London School of Hygiene and Tropical Medicine, 
London, United Kingdom (latest approval LSHTM ethics ref: 6471, dated 29
th
 July 2013). 
Approval was also sought from the village heads and their committees in each of the 29 villages. 
The participants provided written informed consent, or a witnessed thumbprint if illiterate, before 
their inclusion in the study. This analysis received ethical approval from London School of 
Hygiene and Tropical Medicine, London, United Kingdom (LSHTM MSc Ethics Ref: 12242, 
dated 16
th
 June 2017) and Public Health Foundation of India, Gurugram, Haryana, India (TRC-
IEC-349/17 dated 10
th
 July 2017). 
Statistical methods: 
All data are presented as mean (±SD), median (IQR) or as numbers (%). The levels of outcome 
variables (FPG, FI, HOMA-IR and Iscore) were continuous. Corrected serum calcium levels 
were grouped in quartiles. Bivariate comparisons for differences in means, proportions or 
medians of socio-demographics, lifestyle factors, anthropometrics and biochemical parameters 
based on gender (men vs. women) and different quartiles of calcium levels (Q1 to Q4) were done 
using appropriate tests of significance (t-test, analysis of variance (ANOVA), Chi-square test, 
Wilcoxon Rank-sum test and Kruskal-Wallis ANOVA as per data type). As the data were 
correlated at household level, multilevel random-effects regression models (linear or logistic) 
accounting for household clustering were conducted to investigate the association of calcium 
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 quartiles with FPG, FI, HOMA-IR, prevalent prediabetes and type-II diabetes after adjusting for 
socio-demographics [age (years), gender (men/women), degree of urbanization (tertiles)], SLI 
tertiles, life-style factors [tobacco (never/ever), alcohol (never or daily-weekly-monthly or on 
special occasions), physical activity (categories based on physical activity levels as extremely 
inactive, sedentary, moderately active and vigorously active), anthropometrics [BMI (kg/m
2
), 
waist circumference (cm)] as well as endogenous regulators of serum calcium levels such as 
serum phosphorus (mg/dL), serum creatinine (mg/dL) and vitamin-D (ng/ml) in a sub-set. 
Evidence of statistical interactions were assessed by log-likelihood ratio test (LRT) of models 
with and without the interaction terms. We also conducted sensitivity analysis by excluding 
participants who used any anti-hypertensive medications. Missing data for different variables 
were less than 5% and were excluded from the analysis. To assess if observed effects might be 
mediated through chronic inflammation, we employed the Baron and Kenny approach (1986) 
(22, 23) This was done in the random sample of healthy sub-group of participants. Multilevel 
random-effects model for the associations of corrected serum calcium levels with FPG, FI, 
HOMA-IR and prevalent prediabetes were conducted with and without adjustments for Iscore. 
Further, independent associations of Iscore with corrected serum calcium levels, FPG, FI, 
HOMA-IR and prevalent prediabetes were also tested.  All analyses were performed using 
STATA Software, version 10.1 (Stata Corp, College Station, Texas) and the multi-level sampling 
scheme was reflected in all of the analyses. 
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 RESULTS  
(a) Associations of serum calcium levels with markers of dysregulated glucose metabolism 
and prevalent type-II diabetes  
The analysis included 2,699 APCaPS participants aged (mean ± SD) 50.3± 7.0 years (Range: 40-
84 years) with 52.2% women. For the whole population, 86.1% were village dwellers, most with 
no formal education (85.7%). One-fourth of the participants were current tobacco users (24.9%); 
21.5% consumed alcohol regularly; 98.4% ate a non-vegetarian diet and 50.9% reported 
sedentary life-style. Median (IQR) corrected serum calcium was 9.3 (8.9, 9.7) mg/dL, mean (± 
SD) phosphorus was 4.1 ± 0.8 mg/dL and vitamin-D was 20.0 ±9.1 ng/mL [data available for a 
sub-set of participants; N=1713]. These characteristics stratified by sex are shown in Table 1. 
Although serum calcium levels were not different between men and women, there were 
significant differences in serum levels of phosphorus, vitamin-D, creatinine as well as fasting 
insulin. Baseline characteristics stratified by quartiles of corrected serum calcium levels are 
presented in Table 2. Overall, participants in the highest quartile tended to be living in locations 
with higher urbanization score and had higher serum phosphorus, creatinine, fasting glucose, 
fasting insulin, insulin resistance as well as prevalent type-II diabetes.  
Multivariable adjusted results for the association of corrected serum calcium quartiles with 
markers of glucose metabolism and prevalent prediabetes and type-II diabetes are presented in 
Table 3. After adjustments for demographic, lifestyle and anthropometric characteristics, 
participants in the highest calcium quartile were more likely to have higher levels of FI and 
HOMA-IR  with a modest increase in FPG and prevalence of type-II diabetes than those in the 
lowest quartile (Q4 vs. Q1) (FI: β =1.4, 95% CI: 1.2, 1.5 µU/ml, p-trend: <0.001; HOMA-IR: β 
=1.4, 95% CI: 1.2, 1.5, p-trend: <0.001; FPG β = 2.1, 95% CI: -0.9, 5.2 mg/dL, p-trend: 0.058 
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 and prevalent type-II diabetes OR=1.6 95% CI: 1.0, 2.6, p-trend: 0.020]. There was no 
association of serum calcium with prevalent prediabetes and there were no significant 
interactions in associations between serum calcium and the outcomes by sex.  We conducted two 
sensitivity analyses.  First,  in the sub-set with vitamin-D data (N = 1713) a similar pattern but 
with slightly stronger associations was found, including when adjusting for serum levels of 
vitamin-D, phosphorus and creatinine (Supplemental Table 1).  The vitamin D  sub-set 
comprised younger men and women in lower SLI compared to participants who did not have 
vitamin-D data (data not shown). In the second sensitivity analyses we excluded participants who 
regularly used any hypertensive medication (N=188). Again, the results  were similar, although 
slightly attenuated (Supplemental Table 1). 
(b) Mediation of chronic inflammation in associations between serum calcium and markers 
of dysregulated glucose metabolism in a healthy sub-set of participants 
Characteristics of the healthy sub-set of participants (N=1,000) with inflammatory markers 
assessed were similar to the whole population and are shown in Supplementary Table 2 
stratified by sex. Men had a higher inflammatory score (Iscore) than women (mean Iscore: 0.2 (± 
2.4) vs. -0.3 (± 2.2) in women). Men had higher IL-18 but lower IL-6 and adiponectin compared 
to women (p<0.001). While there were no differences in serum calcium levels between men and 
women, levels of serum phosphorus, vitamin-D, fasting insulin and insulin resistence differed 
(Supplementary Table 2). Within the healthy subset, after adjustment for demographic 
characteristics, lifestyle factors and anthropometrics the highest corrected serum calcium quartile 
was positively associated with FI [β = 1.3, 95% CI: 1.2, 1.5, p-trend <0.001 and HOMA-IR [β = 
1.3, 95% CI: 1.1, 1.5,  p-trend <0.001] (Table 4, model 1). On further adjustment with Iscore, 
the associations did not change (Table  4, model 2).  The associations were not materially 
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 different after adjustments for either individual inflammatory markers or the combined Iscore 
(data not shown).  Similar patterns, but with slightly  stronger associations were found in the sub-
set with vitamin-D data (N=687) (Supplemental Table 3). We then assessed if inflammatory 
score  was independently  associated with the glucose dysregulation outcomes FPG, FI, HOMA-
IR and prevalent diabetes and observed significant associations (Q4 vs. Q1)  for all outcomes 
(Table 5). Finally, we assessed if inflammatory score was independently associated with 
corrected serum calcium levels (Table 6) and observed a significant interaction between Iscore 
and sex revealing a positive association only in men. 
DISCUSSION 
In this study, elevated corrected serum calcium levels were significantly associated with markers 
of dysregulated glucose metabolism (increased FI and HOMA-IR as well as FPG), and prevalent 
type-II diabetes but not prevalent prediabetes in a rural Indian population after adjustment for all 
measured potential confounders. When investigated in a sub-set with available data, these 
associations were observed to be independent of endogenous regulators of calcium metabolism 
including serum phosphorus, creatinine and vitamin-D. The findings were consistent, but slightly 
attenuated, after excluding participants who used regular medication for hypertension that could 
have altered calcium metabolism. Furthermore, we observed similar patterns of associations in 
the sub-set of participants who had no self-reported history of chronic disease and in whom 
inflammatory markers were assessed.  Inclusion of IScore in this sub-group as a measure of 
chronic inflammation did not alter the observed measures of association between serum 
corrected calcium and glucose dysregulation. However, Iscore was independently associated 
with markers of dysregulated glucose metabolism in both sexes and with  elevated serum 
calcium levels, but only in men.  
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 Our results are consistent with previous cross-sectional studies in other populations. In South 
Korean adults aged 40+ years, elevated serum calcium was positively associated with type-II 
diabetes and metabolic syndrome (10). Although we did not find any evidence of sex specific 
associations for serum calcium and glucse dysregulation in our study population, these have been 
observed in other populations but not consistently.  In a healthy Canadian population 
significantly higher levels of FBG and HOMA-IR were observed in the high-calcium group 
compared to low-calcium group which was more evident in women than men (12). Conversely, 
in Japanese type-II diabetics significant positive correlations between serum calcium 
and FPG and HOMA-IR were observed  in men (11) but not in women. A study on oral glucose 
intolerance in UK participants aged 40-65 years, found 2-hour plasma glucose to be 
positively associated with total serum calcium and parathyroid hormone (PTH) both among men 
and women. Cohort studies (5-9) conducted so far have mostly confirmed temporal associations 
between elevated serum calcium and incident type-II diabetes. These associations reported across 
different populations were also unaffected by endogenous regulators of calcium metabolism 
including vitamin-D, phosphorus, magnesium, serum creatinine or glomerular filtration rate) as 
well as PTH.  However, a recent prospective study among South East Asians reported no 
association between serum calcium and incident type-II diabetes and on the contrary reported 
higher dietary calcium to be associated with a reduced risk of type-II diabetes development. (24). 
Vitamin-D and PTH may also be independently involved in diabetes risk (8, 25, 26). We did not 
have information on PTH, which could have limited our interpretations in terms of some residual 
confounding. However, the dose-response association (Q4 vs. Q1) was consistent in the overall 
study population as well as across several sub-sets within the study population (i.e., a healthy 
sub-set, a sub-set excluding participants with regular hypertensive medication use as well as a 
D
ow
nloaded from
 https://academ
ic.oup.com
/cdn/advance-article-abstract/doi/10.1093/cdn/nzy085/5144764 by London School of H
ygiene & Tropical M
edicine user on 15 January 2019
 sub-set with vitamin-D data).  The associations with markers of dysregulated glucose 
metabolism and prevalent type-II diabetes were strengthened in the sub-set with vitamin-D data. 
This sub-set included young men and women living in locations with higher urbanization score 
and low SLI.  This might have been a chance finding due to relatively smaller sample size but 
could possibly be indicating high-risk individuals within this population. 
The probable causal role of elevated serum calcium for type-II diabetes is becoming established 
through cohort studies and consistent cross-sectional findings across different populations 
worldwide (4-13, 27).  Randomised clinical trials report prevention and/or stable control of type-
II diabetes using calcium-channel blockers or other medications compared to diuretics  in 
patients with other disease conditions including hypertension (14, 28). 
The proposed mechanisms for the associations of elevated serum calcium on glucose metabolism 
dysregulation include the role of calcium in reducing the function of  glucose transporters on 
adipocytes, (15) altering beta-cell function and increasing insulin resistance. Serum calcium 
levels could be elevated by underlying chronic low levels of inflammation (4, 27). Inflammation 
and elevated calcium could synergistically contribute to organelle dysfunction and damage 
leading to dysregulated glucose metabolism (4, 27). In our study, chronic inflammation did not 
appear to mediate associations between serum calcium and dysregulated glucose metabolism.  
Inadequate measurement of inflammation could have influenced these associations. However, 
although we did not have information on TNF-α and IL-10, important pro- and anti-
inflammatory markers respectively, (29) the use of a composite inflammatory score has been 
shown previously to adequately characterize the overall inflammatory status of the participants 
(21). The role of chronic inflammation in the pathogenesis of type-II diabetes is well established, 
(4, 27). We found independent positive associations of chronic inflammation with markers of 
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 dysregulated glucose metabolism in the healthy sub-set of participants consistent with the 
existing evidence.  
There is a large body of preclinical data (in vitro and animal models) for the elevation of serum 
calcium levels by chronic inflammation (4, 27). We found positive associations of chronic 
inflammation (Iscore) with elevated corrected serum calcium among men, indicating a role for 
chronic inflammation in elevating serum calcium levels. We did not find similar associations 
among women suggesting that the factors for elevated serum calcium in women could be other 
than inflammation. Similar sex-specific differences have been observed with coronary artery 
calcium (CAC) deposition and inflammatory markers wherein adiponectin was found to be 
inversely associated (30) and hsCRP positively associated with CAC in men (31) but not among 
women. It is established that inflammatory responses and its influences on various chronic 
diseases including type-II diabetes are gender-specific due to sex hormones, genetic factors and 
differences in lifestyle risk exposures, (28) but further investigations are required to understand 
the mechanisms better. Inadequate measurement of inflammatory markers specific for women 
such as IFN-γ, IL-10 (28) could also have influenced these associations, however, this is less 
likely as chronic inflammation was associated with markers of dysregulated glucose metabolism.  
Our results suggest that chronic inflammation may not be on the causal pathway between serum 
calcium and glucose dysregulation in our study population, but it remains possible that  it may be 
involved in early elevation of serum calcium levels among men. In this population, serum 
calcium levels and chronic inflammation are associated with glucose metabolism but are acting 
independently of each other. Cautious interpretation of these results is required for the following 
reasons:  (1) inherent limitations of a cross-sectional study design such as reverse causation and 
temporality; (2) potential measurement error of chronic inflammation, although the inflammatory 
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 markers used in our study were among the most commonly used markers to examine disease 
endpoints, and have been validated for calculating inflammatory score in other populations (21) 
and previously associated with calcium and glucose metabolism (4,27,30,31); (3) the association 
between elevated serum calcium and prevalent prediabetes was not evident in this population.  
Despite these limitations, this study possesses considerable merits. This was a rural Indian 
population-based study with adequate sample size to test dose-response. The dose-response 
results for the association of elevated serum calcium with markers of dysregulated glucose 
metabolism and type-II diabetes were stable across different subsets. Our results are in-line with 
scientific evidence available to date and are biologically plausible. Furthermore, we observed 
independent associations of chronic inflammation with dysregulated glucose metabolism and 
serum calcium levels. To the best of our knowledge, this is the first report of the associations of 
elevated serum calcium levels and chronic inflammation on markers of glucose metabolism 
dysregulation, evaluating them as independent risk factors, confounders and mediators in a 
representative rural Indian population. 
CONCLUSIONS  
Consistent with previous observational studies, elevated serum calcium is positively associated 
with markers of dysregulated glucose metabolism and prevalent type-II diabetes in a rural Indian 
population. This association was not mediated through chronic inflammation, but chronic 
inflammation was independently associated with glucose metabolism dysregulation. It remains 
possible that inflammation might be responsible for elevation of serum calcium early in the 
pathway, but only among men. Large scale population-based studies to validate the findings and 
clinical studies  to address its clinical relevance and understand potential sex-specific effects are 
recommended.  
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 Table 1: Participant characteristics of rural Indian men and women aged 40-84 years (N=2699) in Andhra 
Pradesh Children and Parents Study (APCAPS, 2010-12). 
 Men Women p-value* Total 
Number (%) 1291 (47.8) 1408 (52.2)  2699 
Socio-demographic and socio-economic characteristics 
Age (years) [mean (± SD)] 53.6 (± 7.0) 47.3 (± 5.5) <0.0001 50.3 (± 7.0) 
Education [n (%)] 
No formal education 
Primary School (up to class IV) 
Secondary School (class V to X/XII) 
 
969 (75.1) 
228 (17.7) 
94 (7.3) 
 
1342 (95.4) 
52 (3.7) 
13 (0.9) 
 
<0.001 
 
2311 (85.7) 
280 (10.4) 
107 (4.0) 
Occupation [n (%)] 
Unemployed 
Manual labour (skilled/unskilled) 
Skilled non-manual/semi-professional 
 
76 (5.9) 
1166 (90.4) 
48 (3.7) 
 
260 (18.5) 
1139 (80.9) 
8 (0.6) 
 
<0.001 
 
336 (12.5) 
2305 (85.5) 
56 (2.1) 
Standard of living index** [mean (± SD)]                                          27.4 (± 8.1) 26.9 (± 8.4) 0.0966 27.1 (± 8.3) 
Urbanization
# 
(tertiles) [n (%)]            Low 
                                                                Medium 
                                                                High 
467 (36.2) 
397 (30.7) 
427 (33.1) 
513 (36.4) 
441 (31.3) 
454 (32.2) 
 
0.893 
980 (36.3) 
838 (31.0) 
881 (32.6) 
Life-style characteristics [n (%)] 
Tobacco                                                   Never 
                                                               Current 
                                                                Former 
496 (38.4) 
753 (58.3) 
42  (3.2) 
1048  (74.5) 
350 (24.9) 
8 (0.6) 
 
<0.001 
1544 (57.2) 
1103 (40.9) 
50 (1.8) 
Alcohol                                                     Never 
                                                  Daily/most days 
                                                   Weekends only 
                                                              Monthly 
                                                Special occasions 
437 (33.8) 
98 (7.6) 
158 (12.2) 
249 (19.3) 
349  (27.0) 
1073 (76.4) 
5 (0.4) 
13 (0.9) 
59 (4.2) 
255 (18.1) 
 
 
<0.001 
1510 (56.0) 
103 (3.8) 
171 (6.3) 
308 (11.4) 
604 (22.4) 
Physical Activity Level (PAL)  
Extremely inactive 
Sedentary 
Moderately active 
Vigorously active 
 
177 (14.8) 
486 (40.7) 
435 (36.5) 
95 (8.0) 
 
68 (5.2) 
538 (41.4) 
563 (43.3) 
130 (10.0) 
 
 
 
<0.001 
 
245 (9.8) 
1024 (41.1) 
998 (40.0) 
225 (9.0) 
Physical characteristics [mean(±SD)] 
BMI (kg/m
2
) 20.5 (± 3.7) 21.9 (± 4.2) <0.0001 21.2 (± 4.0) 
Waist circumference (cm) 76.8 (± 10.5) 73.4 (± 10.2) <0.0001 75.0 (± 10.5) 
Prevalent hypertension*** [n (%)] 529 (41.0) 396 (28.1) <0.001 925 (34.3) 
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 Regular medication for hypertension [n (%)] 108 (11.5) 80 (7.0) <0.001 188 (9.0) 
Prevalent prediabetes*** [n (%)] 287 (25.0) 291 (23.1) 0.274 578 (24.0) 
Prevalent diabetes*** [n (%)] 122 (9.6) 103 (7.6) 0.060 225 (8.5) 
Regular medication for diabetes [n (%)] 51 (4.0) 46 (3.4) 0.383 97 (3.7) 
Biochemical parameters [mean (±SD)] 
Corrected serum  calcium
$
 (mg/dL) [median 
(IQR)] 
9.3 (8.9, 9.8) 9.3 (8.9, 9.7) 0.8051 9.3 (8.9, 9.7) 
Serum calcium uncorrected (mg/dL) [median 
(IQR)] 
9.8 (9.3, 10.3) 9.7 (9.3, 10.3) 0.1550 9.7 (9.3, 10.3) 
Serum phosphorus (mg/dL) 4.0 (±0.8) 4.2 (±0.8) <0.0001 4.1 (±0.8) 
Serum vitamin-D^ (ng/ml) 19.2 (±10.1) 20.8 (±8.0) 0.0001 20.0 (±9.1) 
Fasting plasma glucose (mg/dL) 99.1 (±27.8) 97.9 (±27.3) 0.2884 98.5 (±27.5) 
Fasting insulin (µU/ml) [median (IQR)] 3.0 (1.6, 5.9) 4.8 (3.0, 7.8) <0.0001 4.1 (2.3, 7.0) 
Insulin resistance (HOMA-IR) [median (IQR)] 0.7 (0.4, 1.4) 1.1 (0.7, 1.9) <0.0001 0.9 (0.5, 1.7) 
Serum creatinine (mg/dL) 0.9 (±0.2) 0.7 (±0.1) <0.0001 0.8 (±0.2) 
* p-values are from t-test, Wilcoxon Rank-sum or chi-square test for difference in means, medians or 
proportions. 
**standardized score based on household assets  
# based on composite score indicating degree of urbanization of the area  
^ data were available for 63.4% of participants (N=1713/2699). Missing data for all other variables were 
<5% except for PAL (7.7%)   
$ total serum calcium corrected-for-albumin using formula: (serum calcium mg/dL) + (0.8 * (4 – serum 
albumin g/dL)) 
*** Hypertension: doctor-diagnosed disease and/or a systolic BP ≥140 mm Hg or a diastolic BP ≥90 mm 
Hg at the time of the interview; diabetes: doctor-diagnosed disease and/or fasting blood glucose (FBG) > 
126 mg/dL at the time of the interview; prediabetes: FBG 100-125 mg/dL at the time of the interview. 
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 Table 2: Distribution of population characteristics by quartiles of corrected serum calcium levels† of 
rural Indian men and women aged 40-84 years (N=2699) in Andhra Pradesh Children and Parents Study 
(APCAPS, 2010-12). 
 Quartiles of corrected serum calcium levels†  
 Q1 Q2 Q3 Q4 p-value 
Median (IQR) (mg/dL) 8.7 (8.5, 8.8) 9.1 (9.0, 9.2) 9.5 (9.3, 9.6) 10.1 (9.9, 10.5)  
Number 654 650 651 651  
Socio-demographic and socio-economic characteristics 
Age (years) [mean (± SD)] 50.1 (7.0) 50.1 (7.1) 50.4 (7.0) 50.7 (7.0) 0.34 
Sex [n (%)]                                            Men                                                          329 (50.3%) 302 (46.5%) 302 (46.4%) 327 (50.2%) 0.28 
Education [n (%)]      No formal education 
                  Primary School (up to class IV) 
           Secondary School (class V to X/XII) 
555 (84.9%) 
72 (11.0) 
27 (4.1) 
552 (84.9%) 
63 (9.7) 
35 (5.4) 
561 (86.2%) 
70 (10.8) 
20 (3.1) 
560 (86.2%) 
66 (10.2) 
24 (3.7) 
0.50 
Occupation [n (%)]                Unemployed 
                                             Manual labour  
         Skilled non-manual/semi-professional 
60 (9.2%) 
579 (88.5) 
15 (2.3) 
89 (13.7%) 
550 (84.6) 
11 (1.7) 
96 (14.7%) 
542 (83.3) 
13 (2.0) 
76 (11.7%) 
552 (86.1) 
14 (2.2) 0.078 
Standard of living index** [mean (± SD)]                                            26.8 (7.9) 27.6 (8.3) 27.9 (8.1) 26.4 (8.7) 0.003 
Urbanization
# 
(tertiles) [n (%)]          Low 
                                                        Medium 
                                                            High 
198 (30.3) 
269 (41.1) 
187 (28.6) 
208 (32.0) 
251 (38.6) 
197 (29.4) 
231 (35.5) 
185 (28.4) 
235 (36.1) 
308 (47.3) 
87 (13.4) 
256 (39.3) 
<0.001 
 
 
Life-style characteristics [n (%)] 
Tobacco                                             Never 
                                                            Ever 
378 (57.9) 
275 (42.1) 
385 (59.2) 
265 (40.8) 
360 (55.3) 
291 (44.7) 
365 (56.2) 
285 (43.8) 
0.48 
 
Alcohol                                              Never 
                                               Daily/weekly 
                         Monthly/Special Occasions 
346 (53.0) 
70 (10.7) 
237 (36.3) 
389 (59.8) 
50 (7.7) 
211 (32.5) 
353 (54.3) 
71 (10.9) 
226 (34.8) 
357 (54.9) 
74 (11.4) 
219 (33.7) 
0.12 
 
 
Physical Activity Level (PAL)  
Extremely inactive 
Sedentary 
Moderately active 
Vigorously active 
39 (7.1) 
217 (39.7) 
249 (4.5) 
42 (7.7) 
59 (10.1) 
243 (41.4) 
235 (40.0) 
50 (8.5) 
65 (10.3) 
282 (44.8) 
232 (36.9) 
50 (7.9) 
72 (11.3) 
247 (38.6) 
244 (38.1) 
77 (12.0) 
0.005 
 
 
 
Physical characteristics [mean(±SD)] 
BMI (kg/m
2
) 20.9 (3.7) 21.3 (3.9) 21.5 (4.3) 21.2 (4.1) 0.025 
Waist circumference (cm) 74.2 (10.1) 75.2 (10.5) 75.8 (10.8) 75.1 (10.3) 0.044 
Prevalent hypertension*** [n (%)] 200 (30.6) 
 
216 (33.2) 
 
240 (36.9) 
 
234 (35.9) 
 
0.071 
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 Prevalent prediabetes*** [n (%)] 137 (22.3) 136 (22.6) 164 (27.9) 132 (22.7) 0.071 
Prevalent diabetes*** [n (%)] 40 (6.1) 48 (7.4) 61 (9.4) 69 (10.6) 0.016 
Biochemical parameters [mean (±SD)] 
Serum phosphorus (mg/dL) 4.0 (1.2) 4.0 (0.6) 4.2 (0.6) 4.4 (0.6) <0.001 
Serum vitamin-D^ (ng/ml) 20.3 (10.2) 19.9 (8.4) 19.3 (8.4) 20.5 (9.3) 0.25 
Fasting plasma glucose (mg/dL) 95.7 (20.0) 96.6 (24.3) 100.6 (29.2) 100.6 (33.1) <0.001 
Fasting insulin (µU/ml) [median (IQR)] 3.6 (2.1, 6.0) 
 
3.8 (2.2, 6.8) 
 
4.3 (2.5, 7.5) 
 
4.5 (2.4, 7.8) 
 <0.001 
Insulin resistance (HOMA score) 
[median (IQR)] 
0.8 (0.5, 1.4) 
 
0.9 (0.5, 1.6) 
 
1.0 (0.6, 1.9) 
 
1.1 (0.5, 1.9) 
 <0.001 
Serum creatinine (mg/dL) 0.8 (0.2) 0.8 (0.2) 0.8 (0.2) 0.9 (0.2) <0.001 
*p-values are from ANOVA, Kruskal-Wallis ANOVA or chi-square test for difference in means, medians or 
proportions **standardized score based on household assets  
# based on composite score indicating degree of urbanization of the area  
^ data were available for 63.4% of participants (N=1713/2699). Missing data for all other variables were <5% 
except for PAL (7.7%)   
† total serum calcium corrected-for-albumin using formula: (calcium mg/dL) + ((0.8 * (4 – albumin g/dL)) 
*** Hypertension: doctor-diagnosed disease and/or a systolic BP ≥140 mm Hg or a diastolic BP ≥90 mm Hg at the 
time of the interview; Diabetes: doctor-diagnosed disease and/or fasing blood glucose (FBG)  > 126 mg/dL at the 
time of the interview; Prediabetes: FBG 100-125 mg/dL at the time of the interview. 
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 Table 3: Associations† of corrected serum calcium levels†† with fasting plasma glucose, fasting insulin, 
insulin resistance, prevalent prediabetes and diabetes in rural Indian men and women aged 40-84 years of 
Andhra Pradesh Children and Parents Study (APCAPS, 2010-12). 
 Fasting 
plasma 
glucose 
(mg/dL)  
(β; 95% CI) 
Fasting insulin* 
(µU/ml)  
(β; 95% CI) 
Insulin 
resistance* 
(HOMA-IR)   
(β; 95% CI) 
Prevalent 
prediabetes  
(OR; 95% CI) 
Prevalent 
diabetes  
(OR; 95% CI) 
Corrected serum 
calcium 
quartiles 
     
Model 1  
Q1 
Q2 
Q3 
Q4 
N=2605 
0.00 (ref) 
0.7 (-2.2, 
3.6) 
4.6 (1.6, 7.5) 
4.6 (1.6, 7.6) 
N=2604 
0.00 (ref) 
1.1 (1.0, 1.2) 
1.3 (1.1, 1.4) 
1.4 (1.3, 1.6) 
N=2603 
0.00 (ref) 
1.1 (1.0, 1.3) 
1.3 (1.2, 1.5) 
1.5 (1.3, 1.6) 
N=2385 
1.00 (ref) 
1.0 (0.8, 1.4) 
1.3 (1.0, 1.8) 
0.9 (0.7, 1.3) 
N=2605 
1.00 (ref) 
1.2 (0.8, 1.8) 
1.6 (1.0, 2.4) 
1.9 (1.2, 2.9) 
p-trend <0.001 <0.001 <0.001 0.749 0.001 
Model 2 
Q1 
Q2 
Q3 
Q4 
N=2394 
0.00 (ref) 
-1.4 (-4.4, 
1.6) 
1.3 (-1.6, 
4.3) 
2.1 (-0.9, 
5.2) 
N=2393 
0.00 (ref) 
1.1 (1.0, 1.2) 
1.2 (1.1, 1.3) 
1.4 (1.2, 1.5) 
N=2392 
0.00 (ref) 
1.1 (1.0, 1.2) 
1.2 (1.1, 1.3) 
1.4 (1.2, 1.5) 
N=2190 
1.00 (ref) 
0.9 (0.7, 1.2) 
1.0 (0.8, 1.4) 
0.7 (0.5, 1.1) 
N=2394 
1.00 (ref) 
0.9 (0.5, 1.5) 
1.1 (0.7, 1.8) 
1.6 (1.0, 2.6) 
p-trend 0.058 <0.001 <0.001 0.206 0.020 
p-interaction by 
sex** 
0.6589 0.3144 0.2690 0.8267 0.4047 
 
Model 1: adjusted for age (years), sex, standard of living index (tertiles), urbanization score (tertiles)  
Model 2: adjusted for age (years), sex, standard of living index (tertiles), urbanization score (tertiles) tobacco 
(never/ever), alcohol (categories), physical activity (categories), BMI (kg/m
2
), waist circumference (cm) 
†Multilevel random-effects linear (for FPG, FI and HOMA-IR) and logistic (for prevalent prediabetes and diabetes) 
regression model.  
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 * Co-efficient and confidence-interval values were back-transformed (e
β
) as outcome variables were natural log 
transformed before analyses 
** likelihood-ratio test for interaction of sex with serum calcium quartiles.  
†† Median (IQR) levels of serum calcium (mg/dL) corrected-for-albumin by quartiles: Q1 – 8.7 (8.5, 8.8); Q2 - 9.1 
(9.0, 9.2); Q3-9.5 (9.3, 9.6); Q4 -10.1 (9.9, 10.5)          
 
 
Table 4: Associations† of corrected serum calcium levels†† with fasting plasma glucose, fasting insulin, 
insulin resistance and prevalent prediabetes in a random sample of healthy rural Indian men and women 
aged 40-84 years (N=1000)
#
 of Andhra Pradesh Children and Parents Study (APCAPS, 2010-12)  
 Fasting plasma 
glucose (mg/dL) 
(β; 95% CI) 
Fasting insulin* (µU/ml)  
(β; 95% CI) 
Insulin resistance* 
 (HOMA-IR)   
(β; 95% CI) 
Prevalent 
prediabetes  
(OR; 95% CI) 
Corrected serum calcium 
quartiles 
    
Model 1 
Q1 
Q2 
Q3 
Q4 
N=917 
0.00 (Ref) 
-1.6 (-5.2, 2.0) 
-0.13 (-3.8, 3.5) 
1.5 (-2.2, 5.2) 
N=917 
0.00 (Ref) 
1.0 (0.9, 1.2) 
1.1 (0.9, 1.2) 
1.3 (1.2, 1.5) 
N=917 
0.00 (Ref) 
1.0 (0.9, 1.2) 
1.1 (0.9, 1.2) 
1.3 (1.1, 1.5) 
N=882 
1.00 (Ref) 
0.8 (0.5, 1.4) 
1.0 (0.6, 1.7) 
0.8 (0.5, 1.4) 
p-trend 0.334 <0.001 <0.001 0.627 
p-interaction by sex** 0.9972 0.0361  0.0634  0.7121 
Model 2 
Q1 
Q2 
Q3 
Q4 
N=914 
0.00 (Ref) 
-1.6 (-5.2, 2.0) 
-0.5 (-4.2, 3.1) 
0.7 (-3.0, 4.4) 
N=914 
0.00 (Ref) 
1.0 (0.9, 1.2) 
1.1 (0.9, 1.2) 
1.3 (1.1, 1.5) 
N=914 
0.00 (Ref) 
1.0 (0.9, 1.2) 
1.1 (0.9, 1.2) 
1.3 (1.1, 1.5) 
N=879 
1.00 (Ref) 
0.8 (0.5, 1.4) 
0.9 (0.5, 1.6) 
0.7 (0.4, 1.3) 
p-trend 0.613 <0.001 <0.001 0.368 
p-interaction by sex** 0.9973 0.0467 0.0818 0.6351 
p-interaction by Iscore
##
 0.6647 0.6499 0.7164 0.6182 
Model 1: adjusted for age (years), sex, standard of living index (tertiles), urbanization score (tertiles), tobacco 
(never/ever), alcohol (categories), physical activity (categories), BMI (kg/m
2
) and waist circumference (cm); Model 
2: Model 1 plus overall inflammatory score;  
† Multilevel random-effects linear (for FPG, FI and HOMA-IR) and logistic (for prevalent prediabetes) regression 
model  
†† Median (IQR) levels of serum calcium (mg/dL) corrected for albumin by quartiles: Q1 – 8.7 (8.5, 8.8); Q2 - 9.1 
(9.0, 9.2); Q3-9.5 (9.3, 9.6); Q4 -10.1 (9.9, 10.5)          
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 * Co-efficient and confidence-interval values were back-transformed (e
β
) as outcome variables were ln-transformed 
before analyses; ** likelihood-ratio test  for interaction of sex and serum calcium quartiles  
# excluding participants with self-reported history of any chronic disease including hypertension, diabetes, 
cardiovascular disease, chronic obstructive respiratory disease and cancer. 
## likelihood-ratio test for interaction of Iscore and serum calcium quartiles (Iscore was categorised as anti-
inflammatory score and pro-inflammatory score based on negative and positive values respectively (21)) 
SLI: Standard of living Index; PAL: Physical Activity Level; HOMA-IR: Homoeostasis-Model-Assessment for 
insulin resistance. 
 
 
Table 5: Associations† of inflammatory score with fasting plasma glucose, fasting insulin, insulin 
resistance and prevalent prediabetes in a random sample of healthy
#
 rural Indian men and women aged 
40-84 years (N=1000) of Andhra Pradesh Children and Parents Study (APCaPS, 2010-12). 
 
 
†adjusted for age (years), sex, standard of living index (tertiles), urbanization score (tertiles), tobacco (never/ever), 
alcohol (categories), physical activity (categories), BMI (kg/m
2
), waist circumference (cm), serum calcium (mg/dL), 
serum phosphorus (mg/dL) and serum creatinine (mg/dL) in random-effects linear/logistic multilevel model.  
# excluding participants with self-reported history of any chronic disease including hypertension, diabetes, 
cardiovascular disease, chronic obstructive respiratory disease and cancer. 
*Inflammatory score was calculated summing the z-scores of markers to create a standardized overall inflammatory 
marker score for each participant as follows: [(z-score IL-6) + (z-score CRP) + (z-score IL-18) + (z-score sICAM1)] 
– [z-score adiponectin] (21).  
** likelihood-ratio test for interaction of sex and inflammatory score quartiles 
 Fasting plasma 
glucose (mg/dL) 
(β; 95% CI) 
(N=913) 
Fasting insulin* 
(µU/ml)  
(β; 95% CI) 
(N=913) 
 
Insulin resistance* 
 (HOMA-IR)   
(β; 95% CI) 
(N=913) 
 
Prevalent 
prediabetes  
(OR; 95% CI) 
(N=878) 
Inflammatory score
* 
Quartiles 
    
Q1 
Q2 
Q3 
Q4 
Ref 
0.01 (-0.01, 0.04) 
0.02 (-0.006, 0.05) 
0.07 (0.04, 0.1) 
Ref 
1.1 (1.01, 1.3) 
1.08 (0.96, 1.2) 
1.3 (1.1, 1.5) 
Ref 
1.1 (1.01, 1.3) 
1.1 (0.96, 1.2) 
1.4 (1.2, 1.6) 
Ref 
1.5 (0.9, 2.8) 
1.2 (0.6, 2.1) 
2.8 (1.5, 5.4) 
p-trend <0.001 0.001 <0.001 0.003 
p-interaction by sex** 0.2701 0.7967 0.7707 0.1256 
D
ow
nloaded from
 https://academ
ic.oup.com
/cdn/advance-article-abstract/doi/10.1093/cdn/nzy085/5144764 by London School of H
ygiene & Tropical M
edicine user on 15 January 2019
 * Co-efficient and confidence-interval values were back-transformed (e
β
) as outcome variables were ln-transformed 
before analyses 
 
 
Table 6: Associations† of inflammatory score with corrected serum calcium levels in a random sample of 
healthy
# 
rural Indian men and women aged 40-84 years (N=1000) of Andhra Pradesh Children and 
Parents Study (APCaPS, 2010-12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
†adjusted for age (years), sex, standard of living index (tertiles), urbanization score (tertiles), tobacco (never/ever), 
alcohol (categories), physical activity (categories), BMI (kg/m
2
), waist circumference (cm) using  random-effects 
linear multilevel model.  
# excluding participants with self-reported history of any chronic disease including hypertension, diabetes, 
cardiovascular disease, chronic obstructive respiratory disease and cancer. 
*Inflammatory score was calculated summing the z-scores of markers to create a standardized overall inflammatory 
marker score for each participant as follows: [(z-score IL-6) + (z-score CRP) + (z-score IL-18) + (z-score sICAM1)] 
– [z-score adiponectin] (21).  
** likelihood-ratio test for interaction of sex and inflammatory score quartiles.  
The associations followed a similar pattern when adjusted for serum levels of phosphorous, creatinine and vitamin D 
in a sub-set with vitamin D data (N=618). 
 
 
  Corrected serum calcium levels
 (β; 95% CI) 
 
 
 
Inflammatory score
* 
Quartiles 
   
 Overall (n=914) Men (N=461) Women (N=453) 
Q1 
Q2 
Q3 
Q4 
Ref 
0.09 (-0.02, 0.2) 
0.1 (0.02, 0.2) 
0.2 (0.1, 0.4) 
Ref 
0.3 (0.1, 0.5) 
0.3 (0.2, 0.5) 
0.4 (0.2, 0.6) 
Ref 
-0.07 (-0.2, 0.09) 
-0.07 (-0.2, 0.1) 
0.2 (-0.01, 0.3) 
p-trend <0.001 <0.001 0.113 
p-interaction by sex**  0.0258 - - 
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